Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pneumococcal surface adhesin A (PsaA) is a 37-kDa metal-binding lipoprotein and a member of the LraI protein family, essential for the virulence of Streptococcus pneumoniae (UniProt: P0A4G2). It functions as the substrate-binding protein for the PsaABC ATP-binding cassette (ABC) transporter, which is the primary system for high-affinity manganese (Mn2+) uptake in the pathogen (McAllister et al., 2004, J. Biol. Chem.). Manganese is a vital cofactor for the pneumococcal superoxide dismutase (SodA), which allows the bacteria to neutralize reactive oxygen species and survive the host's oxidative burst (Couñago et al., 2014, Structure). Additionally, PsaA acts as an adhesin, mediating the attachment of the bacteria to E-cadherin on human nasopharyngeal epithelial cells, a critical step for colonization (Rajam et al., 2008, Crit. Rev. Microbiol.). Due to its high conservation across nearly all known pneumococcal serotypes, PsaA is a leading candidate for next-generation, serotype-independent protein vaccines (Luo et al., 2012, Vaccine). Therapeutic strategies focusing on PsaA typically involve the induction of neutralizing antibodies that block bacterial colonization and impair the pathogen's ability to survive oxidative stress.
Induction of antibodies that inhibit bacterial adhesion to host cells and disrupt manganese acquisition, leading to reduced bacterial fitness and clearance.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pneumococcal surface adhesin A (PsaA) (PsaA).